Arrowhead Pharmaceuticals (ARWR) had the highest return between August 1, 2019 and November 30, 2019 by a mid-cap US stock, returning 150.1%.
Arrowhead Pharmaceuticals (ARWR) had the highest return between August 1, 2019 and November 30, 2019 by a mid-cap US stock, returning 150.1%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.